相关实验视频

Updated: Jul 6, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

福克斯P3遗传多态性对与乙型肝炎病毒-肝细胞癌相关性的影响:一个病例对照研究

Xiaolian Zhang¹, Jinwan Li², Xue Qin¹

¹Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.

|January 4, 2024

概括

在中国人群中,叉盒蛋白3 (FOXP3) 基因的遗传变异与肝细胞癌 (HCC) 风险无关. 这项研究研究了与乙型肝炎病毒相关的HCC相关的FOXP3多态性.

科学领域:

遗传学是一个遗传学.
在瘤学瘤学.
肝病学肝病学是一种肝病学.

背景情况:

叉头盒蛋白3 (FOXP3) 基因多态性与各种癌症有关.
特别是在乙型肝炎病毒 (HBV) 背景下,FOXP3多态和肝细胞癌 (HCC) 风险之间的关联需要进一步调查.

研究的目的:

研究特定FOXP3基因多态 (rs3761547,rs3761548和rs2232365) 与患HBV相关HCC的风险之间的关系.
分析这些多态性在患有HBV-HCC,肝硬化,慢性乙型肝炎和健康对照的患者.

主要方法:

使用基于聚合酶链反应 (PCR) 的方法,对FOXP3多态的基因定型 (rs3761547,rs3761548,rs2232365).
病例控制研究设计涉及156名HBV-HCC患者,109名HBV肝硬化患者,125名CHB患者和188名来自中国人口的健康对照.

主要成果:

与健康对照人群相比,研究的FOXP3多态 (rs3761547,rs3761548,rs2232365) 和HBV-HCC风险之间没有发现统计学意义上的关联.
这种缺乏关联在整体和子组分析中都是如此 (p > 0.05对所有比较).

结论:

研究的FOXP3多态性 (rs3761547,rs3761548和rs2232365) 似乎不是研究中华人群体HBV相关HCC的风险因素.
可能需要进一步的研究来探索其他影响HCC发展的遗传或环境因素.

关键词:

案例控制研究研究这是FOXP3P3的.肝细胞癌是肝细胞癌.在SNP中,SNP是SNP.

更多相关视频

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...